Verana Health Study Using Curated Real-World Data to Replicate Phase III Ophthalmology Clinical Trial Published in OSLI Retina

Verana Health Study Using Curated Real-World Data to Replicate Phase III Ophthalmology Clinical Trial Published in OSLI Retina

CureSearch to lead impact study on cost, treatment benefits of molecular testing for childhood cancer patients

CureSearch for Children's Cancer is collaborating with Children's Oncology Group (COG), Labcorp Drug Development, Pfizer, UTHealth Houston School of Public Health, and Thermo Fisher Scientific on a new study to examine the economic and treatment benefits of molecular testing for childhood cancer patients.

Orbita Launches Solution to Transform Healthcare Website Search Functionality

Orbita, a leading provider of intelligent virtual assistants and workflow automation for healthcare, launched a new solution set to transform the healthcare website experience. Orbita Blaze uses conversational AI and advanced search technology to interpret and address patients’ requests promptly and with precision, so they access the information and care they need.

VisualDx Awarded Grant to Advance Global Health and Diagnostic Accuracy in Underserved Regions

The Bill & Melinda Gates Foundation awarded VisualDx a new grant to develop diagnostic tools for surveillance, detection, and triage of Neglected Tropical Diseases (NTDs) and other rare infectious diseases in India and Nigeria. This project comes on the heels of similar public health collaborations with HHS and the state of Vermont. It also marks the second Gates Foundation grant VisualDx has received, following a successful 2020 project in Botswana to provide an offline version of its clinical decision support tool for users in remote areas.

Netherlands Cancer Institute (NKI) Selects Proscia To Drive Personalized Diagnosis

Transition to modern digital pathology will improve patient care and enable new research breakthroughs

Biopharma PEG Provides PEG Products Used As ADC Linker

About Biopharma PEG As a leading manufacturer of PEG derivatives, Biochempeg is dedicated to being your most reliable partner to provide a chemical synthesis and high-quality PEG linkers. We are committed to promoting the progress of your ADC discovery and development projects. Contact us Biopharma PEG Scientific Inc. Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA TEL: 1-857-366-6766 Fax: 617-206-9595 Email: sales@biochempeg.com Website:https://www.biochempeg.com/

Greenphire Appoints Owen Newman as CFO to Accelerate Company Growth

Greenphire Appoints Owen Newman as CFO to Accelerate Company Growth. The 25-year veteran brings deep expertise in financial management as the need for site and patient-centric solutions for clinical trials increases.

Tune Therapeutics Welcomes Noted Industry Leader Dr. John McHutchison to Board of Directors

Tune Therapeutics, a biotechnology company pioneering the creation of genetic tuning (epigenomic editing) therapies, today announced the addition of John McHutchison AO, MD – former CEO at Assembly Biosciences, Inc., and CSO at Gilead Sciences, Inc. – to its board of directors.

Three Ion Exchange Resins Released: Mixed Bed Resins, Chelating Resins, and Adsorbent Resins

Integrated Development Services for Health Care Products

OncoDxRx’s One-Of-A-Kind Liquid Biopsy PGA Platform Backed by Comprehensive Cancer Pathway Profiling

OncoDxRx’s one-of-a-kind liquid biopsy PGA platform is a breakthrough backed by comprehensive profiling of cancer pathways and anti-cancer drugs.

Why Are Carbon Nanomaterials Favored by Researchers?

CD Formulation Offers 16 types of Food Ingredients as Raw Materials to Manufacture Health Care Products

Drug Discovery: Combining the Power of Computational Chemistry with Multiple Applications

Alfa Chemistry Now Becomes A High-Quality 2D Material Supplier

CCDC Welcomes New Applications for its FAIRE Grants to Advance Structural Science

FAIRE grants provide access to the Cambridge Structural Database, software and training. The Frank H. Allen International Research & Education Programme (FAIRE) provides long-term grants to enable academic research in structural chemistry in over 80 eligible countries. Launched in 2017, the number of research and educational institutions with a FAIRE license nearly doubled in 2022 to 31. The initiative has supported researchers to publish over 100 scientific publications in primary research journals since its launch. With research and education organisations in over 80 countries eligible to apply, the FAIRE programme has the potential to greatly widen its positive impact and new applications are welcomed. Continued engagement with the structural science community through conferences like the Pan African Conference on Crystallography (PCCr3) currently being held in Nairobi, Kenya, aims to grow and further support the FAIRE community.

With SmartRenewal, DrFirst Takes Aim at the Dangers of Entering Medication Renewals by Hand

With SmartRenewal, DrFirst Takes Aim at the Dangers of Entering Medication Renewals by Hand

Thermo Fisher Scientific Joins Momentum Labs as Founding Sponsor of New Biotech Hub in Alachua, Florida

Samsung Biologics receives the Terra Carta Seal in recognition of the company’s commitment to creating a sustainable future

Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment

Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment